Teen Vaccinations against Cervical Cancer Lagging
Key points
- Only about half of the teenage girls in the U.S. have rolled up their sleeves for a controversial vaccine against cervical cancer - a rate well below those for two other vaccinations aimed at adolescents.
- The Centers for Disease Control and Prevention reported Thursday that 49 percent of girls had gotten at least the first dose in the three-shot vaccination series against human papilloma virus, or HPV.
- Some experts think parents are uneasy with the sexual issues attached to the vaccination.
- In contrast, the CDC said about two-thirds of teens have gotten shots for bacterial meningitis and tetanus, diphtheria and whooping cough.
Only about half of the teenage girls in the U.S. have rolled up their sleeves for a controversial vaccine against cervical cancer - a rate well below those for two other vaccinations aimed at adolescents.
The Centers for Disease Control and Prevention reported Thursday that 49 percent of girls had gotten at least the first dose in the three-shot vaccination series against human papilloma virus, or HPV. The sexually-transmitted bug can cause cervical cancer and genital warts.
The reason for the low rate? Some experts think parents are uneasy with the sexual issues attached to the vaccination.
In contrast, the CDC said about two-thirds of teens have gotten shots for bacterial meningitis and tetanus, diphtheria and whooping cough.
###
ATLANTA (AP)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsPromising cervical cancer study
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine. The multi-site…
23 February 2014
NewsInternational team completes systematic, genomic study of cervical cancer
Researchers from the Boston area, Mexico, and Norway have completed a comprehensive genomic analysis of cervical cancer in two patient populations. The study identified recurrent genetic mutations not previously found…
26 December 2013
NewsLeadership void, not lack of money, slows efforts to address cervical cancer
A study by Indiana University public health researchers found that the opportunity for significant progress in addressing cervical cancer across the country is being squandered - not because of a lack of money, but…
